GSK CEO wants to boost investment in R&D

GlaxoSmithKline CEO Jean-Pierre Garnier said he wants to boost investment in research and development of new drugs in order to put the company in place to become the "Microsoft of the pharmaceuticals industry," a vision first proposed by the head of Glaxo Wellcome. "We have a chance to step away from the rest of our competition if we execute our plan well and we're now in a position to do so," he said.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD